Notably, the pharmacogenomic CellMiner Cross-Database (https://discover.nci.nih.gov) shows significant correlations between the expression of DCAF13 and cytotoxicity of the clinical TOP1 inhibitors topotecan and irinotecan across cancer cell lines (Supplementary Data Fig. 6c). The gene discussed is TOP1; the disease is cancer.